​

OS Therapies (OSTX) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChart

OSTX Stock Rating

OS Therapies stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 4 0 4 Strong Sell Sell Hold Buy Strong Buy

OSTX Price Target Upside V Benchmarks

TypeNameUpside
StockOS Therapies-
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$1.36$1.36$1.36
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 2613---4
Mar, 2613---4
Feb, 2613---4
Jan, 2613---4
Dec, 2513---4
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Sep 03, 2024EF HuttonBuyinitialise

Financial Forecast

EPS Forecast

Dec 24 Dec 25 Dec 26 Dec 27
Dec 24Dec 25Dec 26Dec 27
Reported$-0.52$-0.98--
Avg Forecast$-0.64$-0.22$0.04$0.26
High Forecast$-0.64$-0.22$0.32$0.68
Low Forecast$-0.64$-0.22$-0.25$-0.16
Surprise %-18.75%345.45%--

Revenue Forecast

$0 $8M $16M $24M $32M $40M Dec 24 Dec 25 Dec 26 Dec 27
Dec 24Dec 25Dec 26Dec 27
Reported----
Avg Forecast$137.00K$36.67M$25.84M$35.05M
High Forecast$137.00K$36.67M$25.84M$35.05M
Low Forecast$137.00K$36.67M$25.84M$35.05M
Surprise %----

Net Income Forecast

$-30B $-23B $-16B $-9B $-2B $5B Dec 24 Dec 25 Dec 26 Dec 27
Dec 24Dec 25Dec 26Dec 27
Reported$-8.88M$-28.75B--
Avg Forecast$-12.83M$-4.41M$4.42M$5.14M
High Forecast$-12.83M$-4.41M$6.42M$13.63M
Low Forecast$-12.83M$-4.41M$-5.01M$-3.21M
Surprise %-30.77%651778.02%--

OSTX Forecast FAQ

Is OS Therapies stock a buy?

OS Therapies stock has a consensus rating of Buy, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 4 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that OS Therapies is a favorable investment for most analysts.

What is OS Therapies's price target?

OS Therapies's price target, set by 4 Wall Street analysts, averages - over the next 12 months. The price target range spans from - at the low end to - at the high end, suggesting a potential 0% change from the previous closing price of $1.36.

How does OS Therapies stock forecast compare to its benchmarks?

OS Therapies's stock forecast shows a 0% downside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for OS Therapies over the past three months?

  • April 2026: 25.00% Strong Buy, 75.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • March 2026: 25.00% Strong Buy, 75.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 25.00% Strong Buy, 75.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is OS Therapies’s EPS forecast?

OS Therapies's average annual EPS forecast for its fiscal year ending in December 2026 is $0.04, marking a -104.08% decrease from the reported $-0.98 in 2025. Estimates for the following years are.

What is OS Therapies’s revenue forecast?

OS Therapies's average annual revenue forecast for its fiscal year ending in December 2026 is $25.84M, reflecting a 0% decrease from the reported $0 in 2025. The forecast for.

What is OS Therapies’s net income forecast?

OS Therapies's net income forecast for the fiscal year ending in December 2026 stands at $4.42M, representing a -100.02% decrease from the reported $-28.754B in 2025. Projections indicate .